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Abstract This short communication deals with the ques-
tions of how to calculate the expected proportion of
compound heterozygous patients among affected offspring
of consanguineous parents, and how, from an observed
proportion of compound heterozygotes, to calculate both
the proportion of homozygotes not identical by descent and
the frequency of pathogenic alleles in the population. This
estimate of allele frequency may be useful when dealing
with populations with a considerable number of consan-
guineous matings.
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Introduction
In a recent search for offspring of consanguineous matings
affected by autosomal recessive diseases, we came across
four compound heterozygous patients among 38 affected
children. This raised the question of whether this was an
unexpectedly high proportion or not.
In the past, when we reported about a first compound
heterozygous cystic fibrosis (CF) patient with consanguin-
eous parents, we showed that the proportion of affected
children with two alleles not identical by descent (non-IBD)
can be considerable (Ten Kate et al. 1991). However, alleles
non-IBD may still be identical by state (IBS). So the
affected compound heterozygous children are just a subset
of the affected children who do not have both alleles IBD
notwithstanding parental consanguinity.
Therefore, we wondered what proportion of non-IBD
patients with consanguineous parents represent compound
heterozygotes, and what proportion is non-IBD but still
IBS. Secondly, we wanted to know whether it is possible to
calculate the overall pathogenetic allele frequency for an
autosomal recessive disorder on the basis of knowledge of
the proportion of compound heterozygotes among affected
children of consanguineous parents. This might be a useful
application as the current global prevalence of consanguin-
eous marriage is estimated at 10.4%, (Bittles and Black
2009), with much higher percentages in many non-Western
countries.
Methods
We start our exploration with the well-known formula to
calculate the probability of the presence of a given
autosomal recessive disease X in the children of a
consanguineous couple (Li, 1955).
P ðXÞ ¼ Fq þ 1 Fð Þq2 ð1Þ
In this formula, F is the inbreeding coefficient and q is
the total frequency of all pathogenic alleles causing disorder
X. The fraction Fq represents the proportion of affected
children whose alleles are IBD, and the fraction (1−F)q2
corresponds with the proportion of affected children whose
alleles are not IBD.
The fraction (1−F)q2 is composed of two parts—one
part comprising the compound heterozygotes (CH), and the
other part combining all homozygotes non-IBD (HN). The
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relative frequencies of the two sets within the fraction (1
−F)q2 are (in reversed order)
R HNð Þ ¼
Xn
i¼1
a2i ; and ð2Þ
R CHð Þ ¼ 1
Xn
i¼1
a2i ð3Þ
In Eqs. 2 and 3, ai represents the relative frequency of
the ith allele. So its square, ai
2, is the relative frequency of
homozygotes of the ith allele non-IBD.
From Eqs. 1 and 3, it follows that the proportion of
compound heterozygotes, P(CH), among affected children
of consanguineous parents is
P CHð Þ ¼
1P
n
i¼1
a2i
 
 1 Fð Þq2
Fq þ 1 Fð Þq2 ð4Þ
We can now calculate the expected proportion of
compound heterozygotes, P(CH), if we know F, q, and
the relative frequencies of the pathogenic alleles. Converse-
ly, knowing P(CH) by observation, as mentioned in the
introduction, we can estimate R(CH), R(HN), and P(HN), if
we know F and q, as follows:
R CHð Þ ¼ 1
Xn
i¼1
a2i
 !
¼ P CHð Þ  Fq þ 1 Fð Þq
2½ 
1 Fð Þq2
¼ P CHð Þ  F þ 1 Fð Þq½ 
1 Fð Þq ; ð5Þ
R HNð Þ ¼ 1 R CHð Þ; and ð6Þ
P HNð Þ¼R HNð Þ  1 Fð Þq
2
Fq þ 1 Fð Þq2 ¼
R HNð Þ  1 Fð Þq
F þ 1 Fð Þq ð7Þ
We can also calculate q from (4) or (5) if we know P
(CH), F and R(CH) or the relative frequencies of the
pathogenic alleles.
q ¼ P CHð Þ  F þ q  Fqð Þ
1 Fð Þ  R CHð Þ ; from which q can be solved:
ð8Þ
Results
Table 1 shows the dependency of the proportion of
compound heterozygotes among affected offspring of
consanguineous parents, P(CH), upon the parameters F, q,
and R(CH) (see Eqs. 3 and 4). The examples given illustrate
that P(CH) is positively correlated with R(CH) and q, and
negatively with F,—as expected.
Table 2 shows the results of calculations of the frequencies
of homozygotes IBD and non-IBD among affected children
of first cousins, and the total frequency of pathogenic alleles
in the population in case of 10% compound heterozygotes
and with different numbers and relative frequencies of
pathogenic alleles. As the proportion of compound hetero-
zygotes is fixed at 10% in this table, the row sum of the
proportions of homozygotes IBD and non-IBD (third and
fourth columns) add up to 90%. The table shows that
knowledge of the proportion of compound heterozygotes,
the inbreeding coefficient, and the number and relative
frequencies of pathogenic alleles (first and second columns)
allows one to calculate the total frequency of pathogenic
alleles of a gene in the population (fifth column). Not
unexpectedly, the higher the frequency of the major allele,
the higher is the frequency of homozygotes non-IBD and the
higher the total frequency of pathogenic alleles in the
population for a given frequency of compound heterozygotes
among affected offspring of consanguineous matings. The
same trend can be observed for children of second cousins
(data not shown) and other levels of inbreeding.
Discussion
Since our observation of a compound heterozygous CF
patient with consanguineous parents back in 1990, many
more observations of compound heterozygotes in consan-
guineous families have been reported (summarized in
Table 1 Expected proportions of compound heterozygotes among
affected children of consanguineous parents, P(CH), given some
values of F, q, and R(CH), the relative frequency of these compound
heterozygotes among non-IBD affected children
F q R(CH) P(CH)
1/8 0.01 0.1 0.007
0.5 0.033
0.05 0.1 0.026
0.5 0.130
1/16 0.01 0.1 0.013
0.5 0.065
0.05 0.1 0.043
0.5 0.214
1/64 0.01 0.1 0.039
0.5 0.193
0.05 0.1 0.076
0.5 0.380
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Petukhova et al. 2009). Such patients present a problem to
researchers using autozygosity mapping for identification
of recessive disease genes. Still, finding compound hetero-
zygosity among affected children of consanguineous
couples has potential advantages. It may comfort parents,
who thought or were told that their consanguinity was
causally related to the disorder in their children, to learn
now that their consanguinity cannot be blamed for it. The
same applies to some extent for parents who can be told
that there is a considerable chance that the homozygosity in
their affected child is not caused by alleles IBD. Moreover,
the mere existence of compound heterozygotes and the
presence of non-IBD homozygotes among affected off-
spring of consanguineous parents may be of help in
disputes with opponents of consanguineous matings, who
are abundantly present in countries where consanguineous
matings are not customary. As we have shown here, we can
also learn more from the frequency of compound hetero-
zygotes, as this frequency is related to the inbreeding
coefficient, the number and relative frequencies of alleles,
and their total frequency.
While preparing the manuscript of this communication,
we came across the paper of Petukhova et al. (2009). These
authors developed a formula to calculate the frequency of
compound heterozygotes in the presence of inbreeding as
we did, but unfortunately assumed equal frequencies of
disease-causing mutations. As we have shown here, this is a
serious omission and, moreover, far from realistic. A second
difference with their paper is that we did not only calculate
the frequency of compound heterozygotes, but turned the
problem upside down by looking for inferences following
from observed frequencies of compound heterozygotes.
One may question the usefulness of being able to make
these calculations. IfF is known in a certain (sub)population,
then the most straightforward way to estimate q would be
via the prevalence of the disease in that (sub)population. In
practice, however, F and the prevalence of the disease in a
population are seldom known with any certainty. Most of
the times, they are unknown or the estimates are debatable
because of large variances or possible biases. Arriving at
accurate and dependable estimates of both parameters takes
a lot of effort and resources. For this reason, any method to
estimate q from other sources, such as the one we describe,
is an improvement. While estimating F in a population
requires knowledge of the prevalence of consanguineous
matings and the distribution of different degrees of
consanguinity among them, estimating F from a small
number of consanguineous families known to a laboratory
in general is less of a challenge.
Once the total frequency of pathogenic alleles is known,
the frequency of an autosomal recessive disease in a
population, P(D), can be inferred from the total frequency
of disease-causing alleles, especially when the frequency of
consanguineous matings, c, is known as well, using the
equation
P ðDÞ ¼ 1 cð Þq2 þ c Fq þ 1 Fð Þq2  ð9Þ
Others have taken a different approach to calculate
the frequency of a disease in the population by looking
at the proportion of consanguineous parents among
affected children and inferring from there, taking into
account the frequency of consanguineous matings, the
Table 2 Frequencies of homozygotes IBD and non-IBD among children with an autosomal recessive disease whose parents are first cousins
when 10% of these children are compound heterozygotes as well as total frequency of pathogenic alleles in the population for different numbers
and relative frequencies of alleles
Input Output
Alleles Frequencies among affected children Total frequency of pathogenic
alleles in the populationNumber Relative frequency Homozygotes IBD Homozygotes non-IBD
5 0.9; 0.07; 0.02; 0.007; 0.003 0.458 0.442 0.079
0.7; 0.2; 0,05; 0.03; 0.02 0.786 0.114 0.018
0.5; 0.3; 0.1; 0.07; 0.03 0.845 0.055 0.012
0.4; 0.3; 0.2; 0,08; 0.02 0.858 0.042 0.011
0.2; 0.2; 0.2; 0.2; 0.2 0.875 0.025 0.010
3 0.9; 0.07; 0.03 0.457 0.443 0.079
0.7; 0.2; 0.1 0.783 0.117 0.018
0.33333; 0.33333; 0.33333 0,850 0.050 0.012
2 0.9; 0.1 0.444 0.456 0.083
0.7; 0.3 0.762 0.138 0.021
0.5; 0.5 0.800 0.100 0.017
2 Frequencies of homozygotes IBD a d non-IBD among
children with an autosomal recessive diseas whose parents are first
cousins when 10% of these children are compound heterozygotes as
well as total frequency of pathogenic alleles in he populati n for
different numbers and relative frequ ncies of alleles
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total pathogenic allele frequency and the total frequency
of recessives in the general population (Romeo et al.
1985; Koochmeshgi et al. 2002). This method might result
in a biased estimate if the presence of consanguinity of the
parents alerts the physician to think of the possibility of a
recessive disorder and diagnose accordingly, while this
might not have been the case in the absence of
consanguinity. Starting from the proportion of compound
heterozygotes gives an unbiased estimate and therefore at
least represents an additional tool to determine disease
frequency in the general population.
Of course our method has some limitations too. Firstly,
inferences can only be made about the population to which
the cases belong. If a population is non-homogeneous as to
the frequency of consanguineous matings, population
stratification has to be taken into account. Secondly, for
any recessive disorder, the number of compound hetero-
zygotes among affected children of consanguineous parents
will be limited. This means that estimates of the proportion
of compound heterozygotes will tend to have rather wide
confidence intervals, which will persist in derived figures.
Nevertheless, a provisional estimate of the frequency of
pathogenic alleles using our method can be useful before
embarking on larger studies, or as a check when other data
are already available.
Acknowledgment We acknowledge the financial support from the
Netherlands Organization for Health Research and Development
(ZonMw, project no. 60040005)
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
Bittles AH, Black ML (2009) Consanguinity, human evolution and
complex diseases. Proc Natl Acad Sci USA (in press)
Koochmeshgi J, Bagheri A, Hosseini-Mazinani SM (2002) Incidence
of phenylketonuria in Iran estimated from consanguineous
marriages. J Inherit Metab Dis 25:80–81
Li CC (1955) Population genetics. University of Chicago Press, Chicago
Petukhova L, Shimomura Y, Wajid M, Gorroochurn P, Hodge SE,
Christiano A (2009) The effect of inbreeding on the distribution of
compound heterozygotes: a lesson from Lipase H mutations in auto-
somal recessive woolly hair/hypotrichosis. Hum Hered 68:117–130
Romeo G, Bianco M, Devoto M, Menozzi P, Mastella G, Giunta AM,
Micalizzi C, Antonelli M, Battistini A, Santamaria F, Castello D,
Marianelli A, Marchi AG, Manca A, Miano A (1985) Incidence
in Italy, genetic heterogeneity, and segregation analysis of cystic
fibrosis. Am J Hum Genet 37:338–349
Ten Kate LP, Scheffer H, Cornel MC, Van Lookeren Campagne JG
(1991) Consanguinity sans reproche. Hum Genet 86:295–296
40 J Community Genet (2010) 1:37–40
